Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Also, the cadaver studies were human as well. I mention that for folks who would believe otherwise based on some contrarian nonsense.
Message in reply to:
Human studies coming soon! IDE request in the hopper!
Moose, Thanks much for the confirmatory post! I also searched them and came up empty. But Medtronic sure does have their hands in a lot of stuff! Just not seeing any Single Port Robotic Surgery development efforts on display in their patent portfolio.
Someone has to be doing it for them. Somewhere.
If they had patents for single port prior to 2014, they would not have been pursuing and reporting on the multi-armed Hugo with such vigor all this time.
Message in reply to:
These are medironic patents. Search through them and let me know. I checked 2014-2018. Could be patents before that.
I found only one that is recent:
10/26/17 / #20170304617
Stimulation probe for robotic and laparoscopic surgery
https://stks.freshpatents.com/Medtronic-Inc-nm1.php
The patents would be probably inherited from Mazor Robotics or another unknown company that they have bought in Europe perhaps!
https://stks.freshpatents.com/Mazor-Robotics-Ltd-nm1.php
19 days to the Medtronic unveiling... but it has been mentioned several times here that nobody has yet found any patents or applications for Medtronic in the Single Port realm. How is that possible? Well, I know at least one way that is possible!
Message in reply to:
66, HC777 has been very transparent that he is shorting the stock and needs it to go down to cover. Whether it is shady math on the Aspire pricing or just telling people to sell at one point and buy back later to acquire more shares. That is straight out of the playbook that shorters use to legally work the system. Sell now at $1.20 and buy back at 70 cents.... Sell now at $2, take the tax loss, wait 30 days and buy back in at $1.
Bottom line is that they think they have all the time in the world to work this over and they do have some BUT we are close enough to the end that ANYTHING can happen at ANYTIME.
Sell now - wash sale applies and will have to wait 30 days until buying back in. IDE sumbittal is in less then 30 days.
We have 19 days to Medtronic unveiling their surgical robotic platform so at the least, anyone who is thinking of selling should wait for Sept 24th to see what Medtronic has.
HC, first, as I mentioned once before, we can see that your $1.24 figure is a nifty little scare tactic that you keep repeating to drive fear into the readers here. The fact remains their initial purchase was at $1.69 but you insist on adding their sign-on bonus of 680K-ish shares to make Titan look weak at $1.24. All subsequent buys are at $1.88 and are not at their discretion, it is up to Titan as to when and how many shares Aspire is contractually obligated to buy.
If Aspire was dumping shares for short-term profits, they would knowingly be collapsing the PPS while still having an obligation to buy at $1.88 whenever Mr. McNally opts for them to do so. Why do you think they want to jeopardize their future in this fashion? You keep saying short term profits, but the long term loss on the next 20M shares would be much greater than those short term profits on 2.4M shares. Is there a logical rationale/tax strategy that actually supports this theory of yours? Please show the math and include the 20M shares in the future!
Message in reply to:
So, in terms of taxes...say Aspire is playing the game of dump some and then buy some (support it) / dump sum and then buy some (support it).
So follow me and please chime in / share your thoughts so we can ALL better understand 1 firm playing both sides, ok ?
So, we know their cost basis is $1.24 USD....we also know that anything that they dump is at a short-term gain for now. Obviously they will chose FIFO method for taxes IMO. So, am I correct that this will cause the PPS to decline over time ? I mean how can it not ? We don't know the rate of the decline as there are other factors in play as well but don't we know that absent of big news - the trend will be a declining PPS over the next several weeks ?
They (assuming FIFO) dump the first shares received... thing is when they eat through that initial 2.41M gift then they can't change their tax method folks. So then the shares they are buying have a much higher cost basis...so how do they profit from selling those lots then ? I am just trying to understand
Am I wrong that once those 2.41M shares are used up and sold (over time) that things get dicey for ole Aspire ? TIA
Yesterday was a very heavy volume day. So you are saying that normally, based on a longer-term average of 100K shares per day, they can sell 20% of that volume, or 20K shares per day. To sell the 2.45M shares plus the additional 20M shares at 20K shares per day would take about 1122 trading days, somewhere around 5 or 6 years.
Message in reply to:
funds liks Aspire usually sell 20% of the daily volume through vwap on a daily basis. Yesterday it traded 250k shares hence the 50k estimate.
Just a reminder for viewers out there... it never hurts to do the math when reading or reviewing posts.
Yesterday was a high volume day; it might not have been inconceivable that Aspire sold shares yesterday if they were going to do so (which I personally doubt). But for the sake of argument, let's say they did, leaving them 2.45M shares to ditch this month as per an earlier post. At 50K shares per day, it would require 49 more trading days in September to achieve that. Including today (the post was last night), there are only 19 trading days remaining. That means they actually need to sell about 129,000 shares per trading day to reach the "goal" specified. Only 30K shares have traded so far today. 10 day average volume is below 250k, but that is heavily skewed by very high volume after the funding announcement last week. Aside from that, the average daily volume is probably somewhere around... what, maybe 100K? So for Aspire to sell that many shares this month, they need to sell more shares than the non-event daily average, every day, for the rest of the month.
At the rate of 50K shares per day, the additional 20M shares mentioned in the post would require another 400 trading days - closing in on two years from now - to sell all of them. Flooding the market with that many shares above and beyond normal trade volumes would absolutely crush our PPS and render their own investment a near total loss.
This is a basic math analysis, using simple arithmetic, to substantiate that Aspire's investment has to be a long-term investment, completely in line with their stated investment strategy.
Now, everyone is free to do their own math, and I recommend it, in order to validate given data and formulate your own perceptions and opinions from a rational basis, especially when reading posts which appear to have an ulterior motive. When blatant discrepancies such as this are found, be as skeptical as common sense tells you to be. And do the math for yourself!
Message in reply to:
Aspire sold 50k shares today, 2.45M left this month. Then another 20M shares for sale (West Coast Snapper, post # 94957)
If I can find to other link at home, I'll share that as well. It had separate Q1 and Q2 sales numbers (not just deliveries) broken out. I assume it includes both lease and cash/financed sales, but if it excludes lease units, all the better for the future of SP surgery!
I don't recall the source nor can I find it at the moment, maybe I saved the link at home. But...
Last year's results indicated here:
https://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/45087-intuitive-surgical-s-da-vinci-sp-wins-clearance-for-2nd-procedure-category-3-details.html
Here's confirmation of 15 SP systems in 2018:
https://www.dotmed.com/news/story/46632
https://au.finance.yahoo.com/news/intuitive-surgical-da-vinci-sp-125812899.html
Somewhere else I had seen something like 12 more for Q1 and 15 for Q2 with expectations of following the trend.
These are sales figures, not deliveries. Q1 only saw 6 SP systems delivered because of some manufacturing issues. This is from ISRG's Q1 call transcript(https://www.fool.com/earnings/call-transcripts/2019/04/18/intuitive-surgical-inc-isrg-q1-2019-earnings-call.aspx):
Gary S. Guthart -- President & Chief Executive Officer
Okay. On the SP side, the manufacturing constraint was a mechanical thing having to do with frictions and rails and the way these things pull together. I think the team has got it. I think we'll meet our SP shipment plan for the year. So I think they're knocking it down, it's just the timing issue there.
This was from not quite 2 months ago, and I have no idea about the reliability of the data presented (unfamiliar with the source) but they say 34 delivered so far (delivered is different than sold, given the manufacturing issues previously stated by Guthart himself):
https://surgrob.blogspot.com/2019/07/intuitives-strong-numbers.html
I did what I could... It was an honest effort, probably moreso than you expected of me in particular. now back to work!
Message in reply to:
Can you show the board where you got 50-60 sales of SP?
Link?
Thanks
Rocko, thanks for sharing these observations. I have an additional takeaway, or maybe an amplification for one of your points...
With all the griping folks do about Titan, how come we know that Titan finished Human Factors and GLP studies and we know what their Q3 and Q4 and H1 plans are with such a LACK OF TRANSPARENCY? Is anyone beating up on Medtronic or JnJ or Stryker or Verb for LACK OF TRANSPARENCY? Oh, wait... for those folks, they are allowed to maintain industrial secrecy while Titan gets publicly hammered for it here on iHub, even when they don't practice it at all. They are forthcoming with their plans, but beat up for LACK OF TRANSPARENCY! Why? I have no idea.
On a possibly unrelated note, I wonder what the short percentages are for Medtronic and JnJ and Stryker and... And Titan, of course, by comparison to their competitors.
Message in reply to:
Titan is less then 30 days away from Q4 - which includes IDE approval and regulatory submittal. They just completed GLP and human factors. They will be doing human clinical trials as well as 510k submission
Interesting point - we here nothing from
Medtronic or JNJ or Stryker or any biggun about their GLP or their IDE process or their human clinical trials or their regulatory submittal.
Titan is not only the next closest platform to get approved BUT they are way ahead of Medtronic and JNJ when it comes to SINGLE PORT.
Sorry glg... This is not the appropriate forum for good news. That will only make people angry and bring about negative information like when Dr. Fowler farted during an AGM causing the PPS to fall and the company to go bankrupt. And it's been over 24 hours since anyone whined about Paige, as if Mr. McNally had anything to do with her. Besides, I heard Trump likes Titan Medical so it must be evil.
Message in reply to:
https://mayfieldrecorder.com/2019/08/24/titan-medical-nasdaqtmdi-upgraded-to-buy-by-valuengine.html
That was part of my point... Once we can start marketing, we can then consider patent infringement suits, if any actual infringement is occurring. By that time, ISRG could have already sold a lot of SP systems. Where are they at now, about 50 or 60 systems sold? and ramping up...
Mr. Brar continues to get kudos for his stellar IP work. I expect he has thoroughly analyzed competing patents to ensure their design doesn't infringe. On the other hand, given ISRG's history, they don't seem to care as much about other organizations' IP; they will just throw money at the problem after the fact.
Message in reply to:
Titan cannot market a device that isn’t FDA approved
If ISRG is infringing on Titan's patents, I think we need to be marketing our device and be able to show financial loss due to the infringement before we would have a case... So a significant backlog of funds could be due to Titan from ISRG if that was the case. It could turn out to be very reminiscent of the ISRG vs. Computer Motion case which was resolved around 2003 by ISRG buying CM.
glg, can you provide any more details about this ISRG rumor? Private or public rumor? Second hand, third hand, sixth-hand rumor? Your estimate on reliability of the source? Any $ amounts discussed as part of the rumor? Or time frames?
Thanks!
Message in reply to:
here we go.
Also rumor out ISRG seriously considering purchase of TITAN. we shall see.
plot thickens
Mr. Brar retains his status as "The Man!"
Nice PR today! Thanks to all who shared it!
What Aspire CAN do and what they DO are not always the same thing. Maybe they CAN sell their Titan shares immediately, but they should revise their "About Us" page immediately if they do. It starts with:
"Aspire Capital Fund, LLC is a Chicago-based, long-only investment fund focused on making investments in publicly traded companies through the open market as well as direct investments including private placements, PIPEs, registered directs, and public offerings"
LONG-ONLY investment fund. It's what they do.
BigT, thanks for posting the "About Us" link. For those who ignored it the first time:
https://aspirecapital.com/about.php
Also, in the prospectus...
"in consideration for entering into the Purchase Agreement, 1,777,325 Initial Purchase Shares to Aspire Capital for an aggregate sale price of $3,000,000"
Doing this very simple math, one can see their purchase price is just a fraction of a penny below $1.69/share for the initial purchase. HC, I see where you got your $1.24 figure from, by adding the 643k shares to the purchased shares in order to try to maximize the visual impact and diminish the goodness of this extremely good news, but in fairness, that "fee" of 639K shares needs to be split against all shares in the 30 month agreement, with the very reasonable assumption that it agreement will be maximized. Therefore, from the prospectus...
"Up to 18,349,994 common shares assuming sale of $35,000,000 of common shares at a price of $1.88 per common share"
Add in the fee of 639K shares and it is about 18.989M shares, or still over $1.84 per share (35M divided by 18.989M). With no warrants.
I think we are in pretty good shape here. And Aspire apparently agrees because they are willing to put $35,000,000.00 on the line.
I don't know why... maybe PRs were supposed to prop up the PPS instead of crush it, so fewer shares/less dilution would be needed. And we don't know what they have in the bank right now; the HFE PR indicated that Q3 spending was a lot lower than projected because of the new timeline.
Keep in mind this also means they have known about and have been working to this new time line for a while now to have realized the cost shift. They went a while without announcing the slip. Maybe they should have released just the HFE info and Advincula's blurb, and held off on the schedule slip info until after the raise!
But again, all speculation on my part.
Message in reply to:
Why no raise before these prs mustang.u know mcnallys past He’s always done raises With plenty of money left in the bank Now all of sudden he’s gonna wait to we are practically down to nothing And PPS is so low. Something doesn’t jive
They still need money to proceed. Even if Medtronic is to be involved, there may be milestones they need to reach on their own first.
Message in reply to:
Just one question please does today’s announcement totally rule out the medtronic thing,Or is it still possible
I don't see your logic. Their new timelines are extending things out further. How does that try to prop up PPS? It would (and as we see today, it DOES) have the opposite effect.
Message in reply to:
Because they continuously prop up stock by announcing new timelines to drive PPS up then continuously and mysteriously come up short and keep driving PPS down. F u
I agree with Beast, this devicerep post 93587 is a perfect candidate for getting stickied. Maybe it won't play out quite this way, but maybe this post will turn out next year to be a history of how Titan investors reached early retirement!
Livendi, add the lack of insider buying to the conspiracy list! If there is a handshake deal in place with MDT or anyone else, they may be forbidden from insider trading for knowing it is about to explode!
So, barring all these future prospects, we are down a noteworthy amount today, hinting that yes indeed, the raise is about to be announced. I'm still holding.
Adrock, if your DD is correct on multiport for MDT, I'll hypothesize that they also need a single port offering to "rival da Vinci SP" and an MDT/Titan deal would still answer a lot of questions! But I won't put a "Hugo Lives!" bumper sticker on my car. (To any Simpsons fans out there, wasn't Hugo the ugly twin of Bart's up in the attic who didn't turn out to be evil? Odd name for a surgical robot!)
Message in reply to:
rocko wasnt u or was it adrock that said medtronic probabley stole this from jnj,why is this so hard to believe for everybody.like i said im not the brightest bulb but all these coincidences point to something being up,again the zaring hire,no raise yet,timelines for both companies similar and other things others have mentioned and as far as insider buying,do u think mcnally going to risk potential problems with the company past problems with this stuff,is he not going to make tons of money anyhow if this is bought out,the drop in price this week suggests im wrong but if no raise today after hours will more people jump on this medtronic train
Adrock, can you share any of your additional due diligence on this topic? It seems very odd to me that they would specifically call out the da Vinci SP if their offering was multiport.
Hey, maybe it's hybrid! Two ports, each port has a three-armed mechanical alien intruder with tools that flip open like a Leatherman tool! And with True wide-angle stereoscopic visualization!
Kidding, obviously... but I'd still like to hear what else you may have discovered about Medtronic's offering.
Thanks!
Message in reply to:
I believe they are showing the multi port robot soley at the investor conference based on mine DD.
That’s not to say they won’t eventually buy Titan.
HC, who says the unveiling needs to have a name? They can call it the yet-to-be-named single port robotic surgery device.And maybe they'll call it Enos (doubtful). But given that a number of folks here have been researching the progress of the Enos trademark filing, has anyone checked for any Medtronic trademark applications to name it something else?
Message in reply to:
Well THAT is why I am here to say to those considering it...look at the FACTS. Sure its a bit of a gamble BUT:
2) I do not think that Medtronic's unvail can call their yet un-named robot enos IF the trademark office hasn't formally approved it. How can you unveil something IF someone could still oppose it ? Makes no sense. Isn't the entire purpose of the analyst day to show the robot off and call it by name so the world can see ISRG's competition ?
Seeking Alpha said Medtronic developing a surgical device to rival the da Vinci SP and is slated to reveal the device during its Sept. 24 analyst day.
It specified SP, not just the da Vinci family.
They were working on Hugo, a multiport offering, and announced a delay over a year ago. Since then, not a peep that I've seen until this pre-analyst day announcement which says SP. Nobody found SP patents for MDT. Between ISRG and Titan patent coverage, it might be tough for a third organization to put together another device without stepping on those existing patents.
Like I said, I'm not 100% sold on it, but it sure would be a nice explanation to these coincidences.
Message in reply to:
Great to hear from you again! It's hard to ignore all the evidence. I hope it is MDT on 9/24 but prepared for it not to be. Also I thought they didn't specify whether the big release was single or multi port? Maybe I am not remembering that correctly.
Quid, this one is HUGE! MDT lacking IP for single port? How do they go from no IP to showing off their single port offering in such a short period of time?
MDT says (or maybe just implies...)they are going to show the world their new single port offering on Sept 24. All their previous publicized efforts were in the multi-port realm. This large point you just brought up about MDT lacking any single port IP in their portfolio. Coincidental moves with Fowler and Zaring (even Federico) which could be viewed as unusually coincidental. Zaring helped transition Mazor over to Medtronic, and then jumps ship to Titan. Titan appears to be running on fumes financially but they keep running (unlike 2016).
Who wants to add more to the list of unusual "coincidences" which could all be explained by an MDT buyout of Titan? Feel free to do so!
I'm not 100% sold on this buyout scenario being a fact, but I really like how all these things are lining up.
Devicerep, sorry, I'm just catching up on posts and hadn't read yours when I wrote this - obviously we are thinking very similarly.. But feel free to help build a distinct list of questions which would be answered by a Medtronic buyout!
As for a bidding war, maybe that already happened in the background between JnJ and MDT. The Auris buyout model shows milestone requirements for full price; maybe MDT prefers to keep things under wraps until the milestones are met and the whole thing is official. Who knows...
Message in reply to:
Forgot to mention....no MDT IP portfolio for the robot....compared to titan...that's the real puzzler
tootall, where were you in 2016? They WERE out of money. Doors didn't close. And that was with a different team and a product that was still pretty far away from the finish line (they didn't think so but they were... now they are really at the home stretch). They didn't have nearly the patent portfolio they now do, which by itself could be worth the billion dollar buyout you mentioned. Keep in mind that others want to get into this space but they need to work around Titan's patents, making it much more challenging, and therefore making those patents much more valuable. Hell, they could probably license a couple of those to competitors for the cash they need to reach the finish line, but rather than help their competition that much, they are doing the shelf raise.
Message in reply to:
I see many here are talking about a buy out. This for a product that does not yet even have human testing approval. And which needs 40 million or the doors close to the business in less than 2 months. And those same people are talking about a possible billion dollar buy out, thereby giving them an immediate thousand (1,000) percent return. In what may also be a recession type environment that might be immiment.
Smashed through the "resistance level" of $2.47!
Roll Titan! Smashie Smashie!!
We already have experience operating on dozens of pigs! If only porcine hysterectomies were a common procedure at the vets' offices!
Message in reply to:
thes robots will be the future of all veteranary procuders. They will be able to sell I lower version with lower cost without all the bells and whistles
They must have at least atomic capabilities, not to mention a miniature TARDIS. How else can you explain doing a C-section which would mean pulling a complete baby out through a 25mm incision?
Message in reply to:
Titan has atomic surgery capability
SPORT, do you still have any copies of the pictures from a few years ago where our robotic arms were shown with Microline printed on the coating of the arm? Shortly after someone pointed it out on iHub, the pictures were removed from the Titan web site.
I don't know if knowing a supplier would move the needle on our PPS, or if Microline is still in Titan's play book, but I'll back you on the fact that it was Microline in the past.
Message in reply to:
It was without question Microline. You were shown that. If it changed that would be a huge change and unlikely IMO...
No reason to believe it’s not Microline.
None.
Tootall, there's hope for you after all! Most replies which begin with "due respect" are usually devoid of any. It was nice to get a respectful reply which, in the process, sheds some light on the character we only know by your login name.
Message in reply to:
sorry mustang, with due respect, this is my 1c:. I went to the college where Bill did, he was just two years ahead of me. My roomies from where i transferred, were two pro athletes, one is Jeff Komlo, look him up, an NFL QB, and the 4th was himself a great athlete who Scott Fitski broke all his records a Penn state all american and phillly eagle. I am a former QB myself....
The exciteable, energetic Vince Lombardi had substantial success coaching football teams; that doesn't make it the only pathway to success.
People are much more prone to hate him, but Bill Belichick has had more coaching success with his low-key approach and calm demeanor.
I agree with you. There probably are hundreds of companies that are on time and under budget with at least some of their projects.
There are around 30 million companies registered in the US alone. I have no idea how many companies (total) there are around the globe. And I have no idea how many projects each of these companies may be undertaking at any given point in time.
"Hundreds of companies" that are on time and under budget are therefore (by your own numbers) quite rare, especially if expressed as a percentage. It is FAR from the norm.
You can buy whatever you want, and ignore whatever facts you choose to ignore.
Message in reply to:
sorry, not buying it. There are hundreds of companies that are on time or earlier, and under budget. Legitimitely.
Chapter 1: The World of Project Management
"Once upon a time there was a heroine project manager. Her projects were never late. They never ran over budget. They always met contractual specifications and invariably satisfied the expectations of her clients. And you know as well as we do, anything that begins with "Once upon a time..." is just a fairy tale."
"This book is not about fairy tales. Throughout these pages we will be a realistic as we know how to be. We will explain project management tools that we know can help the project manager come as close as Mother Nature and Lady Luck will allow to meeting the expectations of all who have a stake in the outcome of the project."
Texbook: "Project Management In Practice" Third edition, Mantel, Meredith, Shafer, Sutton.
Looks like my "jibberish" is well substantiated in virtually any textbook about the subject. Meeting schedules is not the norm. Ask anyone on the Hugo project at Medtronics!
Message in reply to:
"They are following the schedule and meeting the milestones fairly reliably, which by itself is somewhat remarkable to ANYONE with a project management background."
This is jibberish.
Honeycomb, there is so much disagreement and so little actual information being shared both by the company and by iHub posters that I don't see enough factual information to formulate a cogent letter. Base on that alone, I'm not the guy for this letter writing campaign and I'm not really in favor of it at this point.
I certainly understand and share the general discontent regarding the share price. The general consensus seems to be that we should have a market cap of around $150-$200M by this point. Based on the technology, the patent portfolio, and the market opportunity, I would assess the company value at well over half a billion as it sits, and clearly other influences are keeping our PPS suppressed. Is it shorters? I assume they exert some influence, but I think there has to be more to the story.
As the company and Mr. McNally adhere to the schedule and occasionally make a statement about supporting the share price, we keep sliding. I suspect that one of the big issues here is expectations. When he/they say "support the share price" we expect some ground-breaking announcement which probably is not feasible at the current juncture. They are following the schedule and meeting the milestones fairly reliably, which by itself is somewhat remarkable to ANYONE with a project management background. In a normal world, that should be impressive enough to support the hell out of the share price, but our world is no longer normal, and our PPS is reasonable proof. Titan's idea of supporting the share price appears to be to continue meeting milestones and get this thing to market with no additional delays, but we seem to expect "support the share price" to mean any one of Verb/JnJ/Medtronic/ISRG/etc. will bust out a $50/share offer out of the blue. Or maybe we expect an announcement of a major supplier that they can't announce - in such a competitive marketplace with so few big names in the game, a key supplier may not want to have the Titan affiliation made public, lest a behemoth customer (see above list) take umbrage that their end effector/camera/whatever tech supplier might also be helping their upcoming competition. Some of our "expectations" may not be reasonable, and others may be contractually forbidden.
For the future, I would rather see continued progress on the scheduled milestones instead of having management side-step their development program to add a few dimes to our short-term PPS. The worst part of this is that any upcoming raise will be at our woefully under-valued price, and hence dilution is more severe for us longs. Fact of life in this new reality; the alternative would be for them to focus on share price until the schedule slips - then all PPS progress would be given back AND we would be delayed. I like that their priority is the device, because that's where the true long-term value is derived. Despite the continuation of the pain we feel now, I'm in it for the future.
To return to the topic of the letter... This forum is so divided that sufficient agreement is impossible. Titan may as well be run by Donald Trump when one considers the division, and the level of hatred continually expressed by some here is comparable to that of Trump's detractors. In 2016 when the original letter writing campaign occurred, we easily had 90%+ support in the iHub community; we had clear messages and reasonable questions, and we had extreme luck on our side in that we seemed to evoke some sympathy from Mr. Barker at the time. Now, any such attempt is unlikely to induce any positive change, and could instead stir up a hornet's nest. Does anyone have ideas for real, positive change? You might want certain people to be removed, but unless you have suggestions for replacements who are competent, industry-experienced, and want to trade their current stable, comfortable position for a lower-paying start-up company with a largely disgruntled shareholder base... I don't think anyone here can name such a person. We are lucky to have the team we have. Award-winning patent program, President and VP's with nothing but success on their resumes, and, well... the Rock. Granted, he hasn't exactly earned my trust, but he seems to have earned the trust of the rest of the management team, which is much more important than what I think of him. Or what you think of him.
There has also been a lot of grumbling about the redesign and design freeze. Reading the full PDF of our new analyst coverage, one could see how ridiculously outdated the prior design was. The old system could never have been approved by the FDA. They had years of using the old system, with lots of surgeons able to try it out and submit their comments and opinions back to Titan for extensive legal review before deciding which to release. We had design freeze, now they are building and deploying systems to their selected facilities where the same thing will happen... in time. Folks are doubting the validity of the new design because they haven't heard feedback yet. Checking the milestones, we are just about getting to where some number of surgeons can try it, then submit their opinions which will undergo legal review regarding what can and can't be publicly stated about an unapproved medical device, etc. It's all happening; it's all on the schedule in some form...
Let's let them do their jobs as a medical device R&D company. If we let them do that well, we will all make money in the long run. I am not in favor of trying to upset the apple cart just before the apples are ripe for selling.
Message in reply to:
Quite honestly, there is Nothing to lose by sending a shareholder letter to the board. Welcome Charlie the proper way IMO. Mustang, you did a nice job on the last one - you up to the task for the second ?? They should hear from us
What specifically should we expect? News? A nice but seemingly random jump in PPS? I always watch; we need more info to learn!
Message in reply to:
big up day cumming. watch and learn
Not that I have heard, but it certainly makes sense if that's where they plan to launch initially. Headquarters remains in Toronto, presumably with tax advantages. Domain and Zevex were both out of Utah where Mr. McNally is from, so East Coast is sort of a departure from his history.
Message in reply to:
True enough. But has Titan ever hinted at US office before?
Huge place down there. Teleflex also has an office there. Fairly centrally located to support an East Coast launch.
Message in reply to:
Notice the location? Research Triangle in NC. Same location as Transentrix
"Should"... This stock almost never does what it "Should"!
Message in reply to:
Open today should be around $2.90 USD...what TMD closed at yesterday, reflected in the bid/ask average currently.
Senhance approved for use in Japan. I was wondering why they are up pre-market. Another place to sell one or two robots?
Japan tends to be a fairly tech-savvy marketplace. Something tells me the typical Japanese hospital will wait for something better. Hopefully, SPORT (or whatever it will be called) can fill that market opportunity.
Anyone know if a new name, either for our robot or for our company, might be announced tomorrow?
For acquisition, the buyer needs to be concerned with disposition of all the employees. It's a lot easier and cheaper to deal with 7 employees than 200. Also, 100 is easier than 200, but Trixie isn't getting bought when Auris did. I think that shows that it is more about the technology than anything else, and also further validates single port technology as the future of robotic surgery.
Message in reply to:
I also noticed that Virtual Incision has more employees than Titan Medical and they are so early on in R&D compared to Titan. Does it matter how many employees Titan has at this point? Is it any indicator as to when they will commercialize? Is it 12 months? 18 months? 2 years?
What about Auris that had over 200 employees prior to commericalization or TRXC that had well over 100. Auris went for $5.7B for a niche market and TRXC, who is targeting general abdominal surgery, can't even find a suitor. It will be very interesting how this all plays out.
https://investorshub.advfn.com/Titan-medical-inc-TMD-31287/